Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report

Vionnet, Julien; Pascual, Manuel Antonio; Chtioui, Haithem; Giostra, Emiliano; Majno, Pietro; Decosterd, Laurent; Moradpour, Darius

doi:10.1186/s12876-015-0259-5

Scientific article

Case report

Open access

English

Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report

ContributorsVionnet, Julien; Pascual, Manuel Antonio; Chtioui, Haithem; Giostra, Emiliano; Majno, Pietro; Decosterd, Laurent; Moradpour, Darius

Published inBMC gastroenterology, vol. 15, no. 1, 38

Publication date2015

Abstract

Recurrent hepatitis C virus infection after liver transplantation is associated with reduced graft and patient survival. Re-transplantation for graft failure due to recurrent hepatitis C is controversial and not performed in all centers.

Keywords

Directly acting antiviral
Hepatitis C virus
Liver transplantation
Therapeutic drug monitoring

Affiliation

Research group

Hépatologie chirurgicale (327)

Citation (ISO format)

VIONNET, Julien et al. Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report. In: BMC gastroenterology, 2015, vol. 15, n° 1, p. 38. doi: 10.1186/s12876-015-0259-5

Article (Published version)

Identifiers

PID : unige:72714
DOI : 10.1186/s12876-015-0259-5
PMID : 25887762

Commercial URLhttp://www.biomedcentral.com/1471-230X/15/38

ISSN of the journal1471-230X

690views

254downloads

Creation05/13/2015 2:31:00 PM

First validation05/13/2015 2:31:00 PM

Update time03/14/2023 11:18:27 PM

Status update03/14/2023 11:18:26 PM

Last indexation01/16/2024 6:03:30 PM

Archive ouverte UNIGE

Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report

Recurrent hepatitis C virus infection after liver transplantation is associated with reduced graft and patient survival. Re-transplantation for graft failure due to recurrent hepatitis C is controversial and not performed in all centers.

Technical informations